Lisa Rojkjaer,Rainer Boxhammer,Jan Endell,Mark Winderlich,Christofer Samuelsson
申请号：
US15016330
公开号：
US20160222127A1
申请日:
2016.02.05
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present disclosure describes a pharmaceutical combination of an anti-CD38 antibody and lenalidomide and a pharmaceutical combination of an anti-CD38 antibody and bortezomib.
